The Middle East and Africa health screening market size was valued at USD 7.25 billion in 2025 and is expected to reach USD 14.23 billion by 2033, at a CAGR of 8.8% during the forecast period
The market growth is largely fueled by increased adoption of preventive healthcare practices, expanding diagnostic infrastructure, and enhanced government initiatives to promote early disease screening in both public and private healthcare settings
Furthermore, rising consumer demand for accessible, effective, and early disease detection solutions particularly for conditions such as cancer, diabetes, hypertension, and cardiovascular diseases is establishing health screening as a critical component of preventive medicine across the region. These converging factors are accelerating the uptake of health screening services, thereby significantly boosting overall industry growth